August 24, 2015

Camber Pharmaceuticals last week announced its introduction of its entecavir tablet in 0.5- and 1-mg dosage strengths.

August 21, 2015

Galderma Laboratories has announced that Epiduo Forte (adapalene and benzoyl peroxide) Gel, 0.3%/2.5%, is available in retail pharmacies nationwide and in Puerto Rico. 

August 20, 2015

For this installment of DSN’s Executive Viewpoint series, DSN spoke to Menasha’s Paul Murphy about how Menasha is working to bridge the merchandising strategy gap between pharmacists and front-of-store, which can help improve care.

August 20, 2015

GlaxoSmithKline’s Flonase may not be on today’s top five bestselling cough-cold-allergy-sinus products list, but it won’t be long until the brand breaks through.

August 20, 2015

Since the launch of Nexium 24HR in May of 2014, the brand has generated approximately $300 million, “making it one of the largest and most successful Rx-to-OTC switches,” Ian Read, Pfizer chairman and CEO, recently told analysts.

August 19, 2015

The company is one of the first to launch a generic version of the discontinued Abilify Oral Solution used to treat depression, bipolar disorder and schizophrenia. 

August 19, 2015

A study conducted by researchers at Johns Hopkins Bloomberg School of Public Health has found that Florida’s legislative efforts to curb opioid abuse seem to be having their desired effect. 

August 18, 2015

Aurobindo Pharma Limited announced Tuesday that it had received approval from the Food and Drug Administration for its over-the-counter cetirizine hydrochloride in 5- and 10-mg dosage strengths.

August 17, 2015

The website includes sections about the importance of preventing abuse of prescription drugs and outlines the Food and Drug Administrations guidelines on abuse-deterrent labeling. 

August 11, 2015

Iressa is a once-daily oral medication that targets and blocks the activity of epidermal growth factor receptor-tyrosine kinase.

August 10, 2015

According to the Substance Abuse Mental Health Services Administration, more than 24.5 million people age 12 or older in the U.S. (9.4% of the population) live with substance use disorders.

August 10, 2015
According to Sprout Pharmaceuticals, approximately one-in-three women in the United States suffer from low sexual desire, and one-in-10 women (16 million women total) are distressed by it.
July 27, 2015

The Food and Drug administration announced Friday that it had approved Praluent (alirocumab), a cholesterol-lowering PCSK9 inhibitor injection. 

July 13, 2015

The Food and Drug Administration warns patients that prolonged use of NSAIDs could increase risk of heart attack or stroke. 

July 13, 2015

Otsuka Pharmaceutical and H. Lundbeck A/S announced Friday that their new medication Rexulti (brexpiprazole) had been approved by the Food and Drug Administration as an adjunctive treatment for major depressive disorder (MDD) and a treament for schizophrenia. 

July 1, 2015

Teva Pharmaceuticals announced the U.S.-wide availability of generic Aggrenox (aspirin and extended-release dipyridamole) capsules, which contain that can reduce the risk of stroke, on Wednesday.

June 24, 2015

Aurobindo Pharma Limited has announced that it has received final approval from the U.S. Food and Drug Administration for entacapone tablets USP, 200 mg, the generic equivalent to Comtan Tablets 200 mg.

June 23, 2015

Teva announced Monday that it had introduced its generic version of Focalin XR (dexmethylphenidate hydrochloride) extended-release capsules in a new 20-mg dosage strength. 

June 15, 2015

In the past 12 months ended April 19, Zyrtec (McNeil Consumer Healthcare) continues to dominate the allergy category with total retail sales of $332 million.

June 10, 2015

Despite high-profile efforts to implement abuse-deterrent labels and properties on brand-name opioids, advisory company Avalere Health’s latest research notes a key blind spot in the efforts — accessibility.

June 3, 2015

The Pepcid Tastemakers Restaurant Week will be featured in both New York and Chicago.

May 28, 2015

Camber Pharmaceuticals on Thursday announced that it had launched antipsychotic drug aripiprazole — a generic version of Abilify — in 2-, 5-, 10-, 15-, 20- and 30-mg dosage strength tablets. 

May 19, 2015

Pharmacy Quality Alliance has endorsed three new performance measures to assess the use of opioids. 

May 12, 2015

PharmaSmart was recognized as uniquely qualified among kiosks for use in the diagnosis and treatment of hypertension.